Banque Pictet & Cie SA lessened its stake in shares of Zoetis Inc. (NYSE:ZTS) by 8.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 41,907 shares of the company’s stock after selling 4,000 shares during the quarter. Banque Pictet & Cie SA’s holdings in Zoetis were worth $2,672,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of ZTS. Northwestern Mutual Wealth Management Co. grew its holdings in Zoetis by 16.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock valued at $100,000 after buying an additional 230 shares in the last quarter. Harfst & Associates Inc. grew its holdings in shares of Zoetis by 16.1% during the second quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock worth $117,000 after purchasing an additional 260 shares in the last quarter. Almanack Investment Partners LLC. purchased a new position in shares of Zoetis during the second quarter worth about $119,000. Peddock Capital Advisors LLC purchased a new position in shares of Zoetis during the second quarter worth about $140,000. Finally, Parallel Advisors LLC grew its holdings in shares of Zoetis by 41.1% during the second quarter. Parallel Advisors LLC now owns 2,263 shares of the company’s stock worth $141,000 after purchasing an additional 659 shares in the last quarter. 92.44% of the stock is owned by institutional investors and hedge funds.

Several research analysts have recently commented on ZTS shares. Stifel Nicolaus reissued a “buy” rating and set a $65.00 price objective on shares of Zoetis in a report on Friday, September 1st. Cantor Fitzgerald set a $75.00 price objective on Zoetis and gave the stock a “buy” rating in a report on Monday, August 14th. Zacks Investment Research raised Zoetis from a “hold” rating to a “buy” rating and set a $71.00 price objective for the company in a report on Thursday, October 12th. BidaskClub raised Zoetis from a “buy” rating to a “strong-buy” rating in a report on Tuesday, September 12th. Finally, Deutsche Bank AG lowered Zoetis from a “buy” rating to a “hold” rating and set a $65.00 price objective for the company. in a report on Tuesday, July 25th. One analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $67.65.

Shares of Zoetis Inc. (NYSE:ZTS) traded up $0.38 on Friday, reaching $70.79. The company’s stock had a trading volume of 2,337,803 shares, compared to its average volume of 2,995,809. The stock has a market capitalization of $34,495.12, a price-to-earnings ratio of 32.47, a P/E/G ratio of 2.07 and a beta of 1.02. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80. Zoetis Inc. has a 1-year low of $48.55 and a 1-year high of $71.12.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $0.65 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.02. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.32 billion. During the same quarter in the previous year, the company posted $0.52 earnings per share. The business’s revenue was up 8.5% on a year-over-year basis. equities research analysts anticipate that Zoetis Inc. will post 2.37 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 1st. Shareholders of record on Thursday, November 9th will be given a $0.105 dividend. The ex-dividend date is Wednesday, November 8th. This represents a $0.42 annualized dividend and a yield of 0.59%. Zoetis’s payout ratio is currently 22.11%.

ILLEGAL ACTIVITY NOTICE: This article was published by Daily Political and is the property of of Daily Political. If you are reading this article on another website, it was illegally stolen and republished in violation of international copyright and trademark laws. The legal version of this article can be read at https://www.dailypolitical.com/2017/11/19/zoetis-inc-zts-holdings-trimmed-by-banque-pictet-cie-sa.html.

Zoetis Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.